Back to top

Galectin Therapeutics (GALT) in Focus: Stock Moves Up 13.2%
December 04, 2013

Read MoreHide Full Article
Galectin Therapeutics, Inc. (GALT - Free Report) was a big mover last session, as the company saw its shares rise over 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $5.90 to $9.80 in the past one-month time frame.

The company has seen one negative revision in the past 30 days and its Zacks Consensus Estimate moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher can last.

Galectin Therapeutics currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the generic drugs industry include Jazz Pharmaceuticals plc (JAZZ - Free Report) , Lannett Company, Inc. (LCI - Free Report) and Sucampo Pharmaceuticals, Inc. (SCMP - Free Report) . All these carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

More from Zacks Tale of the Tape

You May Like